PVLA
Palvella Therapeutics, Inc
132.50$
-0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -156.5% | -24.4% | -57.3% | – | – | – | |
| 7.3% | 7.5% | – | – | – | – | |
| – | – | 1.6% | – | – | – | |
| -55.9% | 97.2% | 6.3% | – | – | – | |
| 9.3% | 3.0% | 4.0% | – | – | – | |
| 133.7% | -3.0% | -82.0% | – | – | – | |
| 34.5% | 188.2% | 36.9% | – | – | – | |
| 27.9% | 150.6% | -20.4% | – | – | – | |
| -165.8% | -27.4% | -57.3% | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.